Wolfgang Timmer

1.4k total citations
32 papers, 908 citations indexed

About

Wolfgang Timmer is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Wolfgang Timmer has authored 32 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 7 papers in Surgery. Recurrent topics in Wolfgang Timmer's work include Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Nausea and vomiting management (4 papers). Wolfgang Timmer is often cited by papers focused on Asthma and respiratory diseases (11 papers), Inhalation and Respiratory Drug Delivery (6 papers) and Nausea and vomiting management (4 papers). Wolfgang Timmer collaborates with scholars based in Germany, United States and United Kingdom. Wolfgang Timmer's co-authors include Thomas D. Bethke, W Wurst, Klaus F. Rabe, Alexandros Sagkriotis, K. Viel, Markus Neuhäuser, Paul A. Reilly, V. Leclerc, Gerhard Nehmiz and Michael Koenen‐Bergmann and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Wolfgang Timmer

32 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Timmer Germany 17 465 408 169 129 86 32 908
Alan K. Kamada United States 13 523 1.1× 385 0.9× 67 0.4× 54 0.4× 30 0.3× 29 883
Jim Mann United Kingdom 13 256 0.6× 111 0.3× 107 0.6× 136 1.1× 23 0.3× 22 785
Iris Osberg United States 18 191 0.4× 513 1.3× 128 0.8× 124 1.0× 64 0.7× 25 1.2k
Yu Cao China 16 101 0.2× 117 0.3× 144 0.9× 131 1.0× 146 1.7× 69 762
Jerry Herron United States 14 276 0.6× 149 0.4× 38 0.2× 45 0.3× 33 0.4× 20 573
Hailing Yang China 13 143 0.3× 92 0.2× 113 0.7× 45 0.3× 25 0.3× 31 500
Kareena Schnabl Canada 16 129 0.3× 110 0.3× 139 0.8× 91 0.7× 65 0.8× 24 792
Mun Su Chung South Korea 16 92 0.2× 201 0.5× 76 0.4× 98 0.8× 13 0.2× 44 579
Staffan Edsbäcker Sweden 24 812 1.7× 856 2.1× 88 0.5× 231 1.8× 7 0.1× 41 1.6k

Countries citing papers authored by Wolfgang Timmer

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Timmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Timmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Timmer more than expected).

Fields of papers citing papers by Wolfgang Timmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Timmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Timmer. The network helps show where Wolfgang Timmer may publish in the future.

Co-authorship network of co-authors of Wolfgang Timmer

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Timmer. A scholar is included among the top collaborators of Wolfgang Timmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Timmer. Wolfgang Timmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruijnzeel, P. L. B., Achim Wach, Leon Hooftman, et al.. (2019). Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis. Journal of Cystic Fibrosis. 19(2). 299–304. 40 indexed citations
2.
Moschetti, Viktoria, Maria Kim, Michael Sand, et al.. (2018). The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers. European Neuropsychopharmacology. 28(5). 643–655. 10 indexed citations
3.
Gutacker, Michaela, et al.. (2015). Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open‐label, crossover phase 1 study. Clinical Pharmacology in Drug Development. 4(5). 377–386. 9 indexed citations
4.
Homburg, Ursula, Harald Renz, Wolfgang Timmer, et al.. (2015). Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma. Journal of Allergy and Clinical Immunology. 136(3). 797–800. 38 indexed citations
5.
6.
Timmer, Wolfgang, Petra Moroni-Zentgraf, Piet J.G. Cornelissen, et al.. (2014). Once-daily tiotropium Respimat® 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma. Respiratory Medicine. 109(3). 329–338. 45 indexed citations
7.
Baldoni, Daniela, Marcelo M. Gutierrez, Wolfgang Timmer, & Jasper Dingemanse. (2013). Cadazolid, a novel antibiotic with potent activity against Clostridium difficile: safety, tolerability and pharmacokinetics in healthy subjects following single and multiple oral doses. Journal of Antimicrobial Chemotherapy. 69(3). 706–714. 48 indexed citations
8.
9.
Baumann, Sybille, et al.. (2012). An evaluation of the drug interaction potential of netupitant with digoxin.. Journal of Clinical Oncology. 30(15_suppl). e19530–e19530. 1 indexed citations
10.
11.
12.
Rabe, Klaus F., Wolfgang Timmer, Alexandros Sagkriotis, & K. Viel. (2008). Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. CHEST Journal. 134(2). 255–262. 91 indexed citations
13.
Brand, Peter, et al.. (2007). Lung Deposition of Radiolabeled Tiotropium in Healthy Subjects and Patients With Chronic Obstructive Pulmonary Disease. The Journal of Clinical Pharmacology. 47(10). 1335–1341. 38 indexed citations
14.
Voshaar, Thomas, et al.. (2007). A randomized study of tiotropium Respimat® Soft MistTM Inhaler vs. ipratropium pMDI in COPD. Respiratory Medicine. 102(1). 32–41. 45 indexed citations
15.
Timmer, Wolfgang, V. Leclerc, Guillaume Birraux, et al.. (2002). The New Phosphodiesterase 4 Inhibitor Roflumilast Is Efficacious in Exercise‐Induced Asthma and Leads to Suppression of LPS‐Stimulated TNF‐α Ex Vivo. The Journal of Clinical Pharmacology. 42(3). 297–303. 99 indexed citations
16.
Feuring, Martin, Wolfgang Timmer, Markus Neuhäuser, et al.. (2001). The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. Journal of Allergy and Clinical Immunology. 108(4). 530–536. 57 indexed citations
17.
Schmidt, Bernhard M. W., et al.. (1999). The New Topical Steroid Ciclesonide Is Effective in the Treatment of Allergic Rhinitis. The Journal of Clinical Pharmacology. 39(10). 1062–1069. 36 indexed citations
18.
Kleist, Peter, et al.. (1997). Concomitant administration of the ?-glucosidase inhibitor voglibose (AO-128) does not alter the pharmacokinetics of glibenclamide. European Journal of Clinical Pharmacology. 53(2). 149–152. 14 indexed citations
19.
Fuder, H., M. Hartmann, Wolfgang Timmer, et al.. (1996). Lack of pharmacodynamic and pharmacokinetic interaction between pantoprazole and phenprocoumon in man. European Journal of Clinical Pharmacology. 51(3-4). 277–281. 18 indexed citations
20.
Fuder, H., M. Hartmann, Wolfgang Timmer, et al.. (1995). Lack of pharmacokinetic and pharmacodynamic interaction of pantoprazole and phenprocoumon in man. Gastroenterology. 108(4). A86–A86. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan K. Kamada Breakdown of academic impact, for papers by Jim Mann Breakdown of academic impact, for papers by Iris Osberg Breakdown of academic impact, for papers by Yu Cao Breakdown of academic impact, for papers by Jerry Herron Breakdown of academic impact, for papers by Hailing Yang Breakdown of academic impact, for papers by Kareena Schnabl Breakdown of academic impact, for papers by Mun Su Chung Breakdown of academic impact, for papers by Staffan Edsbäcker
Rankless by CCL
2026